An enzyme has been partially purified from canine and porcine cerebral cortical extracts that differs from trypsin in that it manifests some degree of hormone specificity since it converts porcine cholecystokinin to smaller immunoreactive forms, i.e., the COOH-terminal dodecapeptide and octapeptide fragments, but fails to convert big gastrin (34 amino acids) to heptadecapeptide gastrin. This enzyme is distinguishable from trypsin not only in substrate specificity, but also in several physicochemical proprties. It is not inhibited in the presence of concentrations of lima bean trypsin inhibitor sufficient to inhibit 1 mg of trypsin r ml of incubation mixture. Over the past decade it has become evident that many, if not all, peptide hormones are found in their tissues of origin in more than one form (see ref. 1 for review). Following the discovery that proinsulin is the precursor of insulin (2) it has generally been assumed that, if the larger hormonal form contains a peptide with amino acid sequence identical to or if it is convertible by enzymatic conversion to a smaller, well-characterized, and more biologically active form, the larger molecule is a prohormone, whether or not the biosynthetic precursor relationship has been established. Thus, a precursor relationship has been definitely established for several peptide hormones, including proinsulin (2) and proparathyroid hormone (3-5), but it has only been assumed for others, such as big (34-amino-acid) gastrin (gastrin-34) (6, 7) and the 39-amino-acid cholecystokinin variant (CCK-39) (8). Similarly, cholecystokinin (CCK-33) can be considered to be a precursor for the cholecystokinin dodecapeptide and octapeptide (CCK-8), the COOH-terminal fragments which have biologic potencies greater than that of the presumed parent CCK-33 molecule.
Over the past decade it has become evident that many, if not all, peptide hormones are found in their tissues of origin in more than one form (see ref. 1 for review). Following the discovery that proinsulin is the precursor of insulin (2) it has generally been assumed that, if the larger hormonal form contains a peptide with amino acid sequence identical to or if it is convertible by enzymatic conversion to a smaller, well-characterized, and more biologically active form, the larger molecule is a prohormone, whether or not the biosynthetic precursor relationship has been established. Thus, a precursor relationship has been definitely established for several peptide hormones, including proinsulin (2) and proparathyroid hormone (3) (4) (5) , but it has only been assumed for others, such as big (34-amino-acid) gastrin (gastrin-34) (6, 7) and the 39-amino-acid cholecystokinin variant (CCK-39) (8) . Similarly, cholecystokinin (CCK-33) can be considered to be a precursor for the cholecystokinin dodecapeptide and octapeptide (CCK-8), the COOH-terminal fragments which have biologic potencies greater than that of the presumed parent CCK-33 molecule.
Although several groups have reported on the existence in the tissues of origin of tryptic-like enzymes involved in the conversion of proinsulin (9) and proparathyroid hormone (10, 11) , precursors to insulin and parathyroid hormone, respectively, no evidence has as yet been presented to determine whether the same enzyme may be involved in processing more than one hormonal family. In this report we characterize and partially purify 10 ,000 X g for 15 min. The supernatants were tested for ability to convert CCK-33 and gastrin-34 to smaller immunoreactive forms as described below. They were also chromatographed on 1 X 50 cm columns containing Sephadex G-50 or G-75. The columns were calibrated by application of radioactive markers to establish the positions of the void volume and the radioiodide peak. After application of brain extract, the columns were eluted with 0.9% NaCl and 1-ml fractions were collected and tested for enzymatic activity.
The active fractions from the Sephadex column were also centrifuged at 190,000 X g for 2 hr. Portions of the supernatant and resuspended pellets were then layered above a continuous 10-40% sucrose gradient in a 5-ml polyethylene tube and centrifuged at-45,000 rpm for 22 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
or the various fractions from the separation systems with pCCK or gastrin-34, usually at concentrations of 500 ng/ml in 0.25 M phosphate buffer (pH 7.5), fortified with 1 mg of human serum albumin per ml. The incubation was generally carried out at 250C for 60 min. At the end of that time the samples were boiled for 5 min to inactivate the enzyme. The substrates, before and after enzymatic digestion, were then fractionated by starch gel electrophoresis or Sephadex gel filtration. Radioimmunoassay of the eluates was then used to determine alterations in substrate induced by enzymatic conversion. The same substrates were labeled with 125I and fractionated similarly as well as on paper chromatoelectrophoresis, and the enzymatic degradation of labeled and unlabeled substrates was compared.
The activity and specificity of the brain enzyme were compared with those of chymotrypsin-free trypsin (Sigma, bovine trypsin, DCC-treated type XI) at a concentration of 1 mg/ml. The active fraction from the Sephadex purification of the brain extract was used at a concentration of 40,gl of active fraction per ml of incubation volume. The effect of temperature on enzymatic activity was tested at 25°, 379, 450, and 55'C by preincubating each of the enzymes for 15 min to bring it to temperature, then adding each of the two 125I-labeled substrates and incubating for 60 min longer at the four temperatures. The pH range of activity of both enzymes was evaluated by incubation of enzyme and substrate at pH 4.5-9. For some studies excess lima bean trypsin inhibitor (1 mg/ml, sufficient to inhibit 3.2 mg of trypsin per ml) was added to both enzymes before addition of each of the labeled and unlabeled substrates. In some studies an extract from the spleen prepared similarly to the brain extract was tested for enzymatic activity with both unlabeled substrates. In all cases the samples were boiled for 5 min to inactivate the enzymes before fractionation in the various physicochemical systems to test for enzymatic conversion.
Radioimmunoassay. The gastrin and CCK peptides were measured by radioimmunoassay according to published methods (12) (13) (14) . 125I-Gastrin-17 (porcine heptadecapeptide gastrin was a gift from R. A. Gregory through the courtesy of Morton Grossman, Wadsworth, VA) was used as tracer for both assay systems. The guinea pig antiserum used for the gastrin assay does not crossreact with CCK or CCK-8 (13 (12, 13) .
RESULTS
125I-pCCK, in common with many peptide hormones such as insulin, corticotropin, and parathyroid hormone, remains at the site of application when applied to paper for chromatoelectrophoresis while the serum proteins, iodide, and other more acidic peptides such as gastrin, CCK-8, and fragments such as the iodotyrosines migrate anodally (12) . Therefore, in this system it is difficult to distinguish total proteolytic degradation from specific cleavage to a fragment of CCK such as CCK-8. However, paper chromatoelectrophoresis does serve as a rapid screening test for degradative activity. Shown in Fig. 1 Fig. 2 . Trypsin converted labeled and unlabeled gastrin-34 to a peptide having the starch gel electrophoretic behavior of gastrin-17 (Fig. 2 right, bottom) . It also converted labeled and unlabeled CCK-33 to a peptide resembling CCK-8 ( Fig. 2 left, bottom) . However, the Sephadex G-50 void volume eluate of the brain extract, which converted CCK-33 to smaller immunoreactive peptides resembling CCK-12 and CCK-8 ( Fig.  2 left, middle) , did not alter gastrin-34 (Fig. 2 right, molecular size. Thus, the brain enzyme activity is found in the void volume eluates on Sephadex G-75 fractionation while trypsin appears in eluates at about 34% of the volume between the void volume and the radioiodide peak. The void volume fraction was centrifuged at 190,000 X g for 2 hr. The pellet was resuspended in the original volume of saline. The enzyme activity of the supernatant equalled that of the resuspended pellet. Portions of both fractions were then subjected to density gradient ultracentrifugation and their sedimentation pattern was compared with that of 125I-albumin, 125I-gamma globulin, and trypsin. Consistent with its known molecular size, the tryptic proteolytic activity is recovered above albumin in the ultracentrifuge tube while the brain enzyme activity both of the supernatant and of the resuspended pellet is found below gamma globulin.
The species specificity of the brain enzyme was also investigated. The potency of canine cerebral cortex extracts in converting pCCK to the smaller peptide did not differ significantly from the potency of the porcine cerebral cortex extracts.
An enzyme similar to the brain enzyme could not be found in the spleen. Splenic extracts prepared similarly to the brain extracts completely destroyed the immunoreactivity of both CCK-33 and gastrin-34, suggesting the presence of nonspecific proteolytic enzymes. The void volume eluates of Sephadex G-75 filtration of the spleen extracts, prepared similarly with the brain extracts, did not alter CCK-33.
DISCUSSION
Steiner and associates (9) have hypothesized that trypsin-like and carboxypeptidase B-like proteinases have important roles in the conversion of proinsulin into insulin as well as in the intracellular processing of a variety of other precursor forms and were able to demonstrate the existence of similar enzymatic activities in the Islets of Langerhans. However, they were unable to implicate those enzymes directly in the endogenous conversion process. MacGregor et al. (10) and later Habener et al. (11) have demonstrated that subcellular fractions of bovine parathyroid tissue contain enzymatic activity capable of specifically converting the prohormone to intact parathyroid hormone. None of these groups has presented evidence indicating whether the converting enzyme studied was active in converting two or more prohormones to smaller forms.
The present study was undertaken because of the demonstration that the cerebral cortical tissues from several mammalian species contain CCK peptides in amounts comparable to those found in the gastrointestinal mucosa and that the fraction of the immunoreactivity in components smaller than CCK-33 is greater in the brain than in the gut (15) . These observations suggested to us that brain extracts might contain an enzyme of high potency for the specific conversion of CCK-33 to the smaller hormonal forms. The question answered by these studies is that the brain enzyme, which is capable of cleaving CCK-33 at the Arg-Ile bond to yield CCK-12 and at the ArgAsp bond to yield CCK-8, is more specific than simply tryptic-like since, unlike trypsin, it fails to cleave big gastrin at the Lys-Lys-Glu bonds. Furthermore, this enzyme can also be distinguished from trypsin not only in terms of substrate specificity, but also in terms of molecular size, temperature stability, and behavior in the presence of trypsin inhibitor.
Although the brain enzyme appears to manifest hormone specificity, it does seem to effect cleavage at two different sites, as shown by its ability to generate both CCK-12 and CCK-8. This raises the possibility that there are two different but closely related enzymes between which we have been unable to distinguish because our purification methods are as yet relatively crude. There is no evidence that the enzyme is species specific in that both canine and porcine cortical extracts appear to be equally effective in cleaving porcine CCK-33. Thus, there is Medical Sciences: Straus et al. 5713 Medical Sciences: Straus et al.
no reason to believe that the failure of porcine brain enzyme to convert human gastrin-34 to gastrin-17 was due to species specificity. The enzyme has some degree of organ specificity in that a degradative enzyme of the same molecular size was not detectable in splenic extracts, which contain nonspecific proteases capable of completely degrading CCK.
In our studies we have had no problem solubilizing a major fraction of the converting enzyme. The supernatant fraction, after centrifugation for 2 hr at 190,000 X g, contained half the activity and this activity was shown to be associated with a molecule somewhat larger than gamma globulin. We have not yet determined whether the packaging of converting enzyme and the CCK hormonal substrate is different in the brain from in glandular tissue or whether there is a converting enzyme in gut that is as easily solubilized.
It is of interest to consider some possible comparisons between the CCK-converting enzyme system described here and the kidney renin-brain isorenin systems (see ref. 16 
